Suicide characteristics in patients with marked treatment-resistant major depressive disorder: A RECOVER trial report
Journal of Affective Disorders · 2025
DOI: 10.1016/j.jad.2024.12.072 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Victoria C de Leon und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Washington University in St. Louis, St. Louis, MO, USA. Electronic address: deleonv@wustl.edu. Hauptthemen laut MEDLINE: Major Depressive Disorder, Depressive Disorder, Treatment-Resistant, Suicide, Attempted, Vagus Nerve Stimulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Centers for Medicare and Medicaid Services, Cerebrotech Medical Systems.
Abstract (Originalsprache)
BACKGROUND: Suicide attempts are a major concern in major depressive disorder (MDD), especially for those with multiple prior unsuccessful treatment trials. This report compares baseline demographic, clinical features, and treatment history of participants with marked treatment-resistant, nonpsychotic MDD based on lifetime history of suicide attempt (SA vs NSA). METHODS: RECOVER is a randomized, sham-controlled trial of vagus nerve stimulation and the largest such trial of a psychiatric neuromodulation intervention. Baseline data were analyzed. Univariate analyses (SA vs NSA) and logistic regression with backward selection (variables with univariate p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Washington University in St. Louis, St. Louis, MO, USA. Electronic address: deleonv@wustl.edu.
- Seattle Neuropsychiatric Treatment Center, Seattle, WA, USA.
- Center for Interventional Psychiatry, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
- Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.
- Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt Health System, Baltimore, MD, USA.
- Offices of Psychiatry and Counseling Services, Moosic, PA, USA.
Förderung
- Centers for Medicare and Medicaid Services
- Cerebrotech Medical Systems
Zitieren
APA
de Leon, V. C., Allen, R. M., Quevedo, J., Riva-Posse, P., Aaronson, S. T., Berger, M. A., Zajecka, J., Banov, M. D., Manu, L. M., Sheline, Y. I., Farrington, J., Eloge, J. C., Beard, J., Kriedt, C. L., Gott, B. M., Brown, H., Bunker, M. T., Lee, Y. L., Rush, A. J., …, & Conway, C. R. (2025). Suicide characteristics in patients with marked treatment-resistant major depressive disorder: A RECOVER trial report. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.12.072
Vancouver
de Leon VC, Allen RM, Quevedo J, Riva-Posse P, Aaronson ST, Berger MA, et al. Suicide characteristics in patients with marked treatment-resistant major depressive disorder: A RECOVER trial report. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2024.12.072
BibTeX
@article{deLeon2025,
author = {de Leon, Victoria C and Allen, Rebecca M and Quevedo, João and Riva-Posse, Patricio and Aaronson, Scott T and Berger, Matthew A and Zajecka, John and Banov, Michael D and Manu, Lucian M and Sheline, Yvette I and Farrington, Julie and Eloge, Joshua C and Beard, Judy and Kriedt, Christopher L and Gott, Britt M and Brown, Hunter and Bunker, Mark T and Lee, Ying-Chieh Lisa and Rush, A John and Sackeim, Harold A and Conway, Charles R},
title = {Suicide characteristics in patients with marked treatment-resistant major depressive disorder: A RECOVER trial report},
journal = {Journal of Affective Disorders},
year = {2025},
doi = {10.1016/j.jad.2024.12.072}
}
EUVIMED